YCYujia Chen

Yujia Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yujia Chen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Meniga Shengbu

    State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication
  • Qian Shi

    State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication
  • Suolang Jiaqiu

    State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication
  • Xianrong Lai

    State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication
  • Xinan Liu

    State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication

Latest Publications

  • Open Access

    Biomarkers: New Advances in Diabetic Nephropathy

    by Yujia Chen, Xinan Liu, Meniga Shengbu, Qian Shi, Suolang Jiaqiu, Xianrong Lai

    Diabetic nephropathy (DN) is the leading cause of uremia and clinical mortality, characterized by the progressive deterioration of kidney structure and function due to prolonged exposure to hyperglycemia. This condition often necessitates renal replacement therapy for patients with end-stage-renal-disease (ESRD). Consequently, early detection, diagnosis, and treatment of DN are crucial to mitigate disease progression, enhance patient outcomes, and maintain a good quality of life. Exploring relevant biomarkers for the early diagnosis of DN holds significant importance. In recent years, numerous researchers have identified various novel biomarkers associated with diabetic nephropathy, which are critical for predicting both the onset and progression of the disease. This article aims to provide a comprehensive overview of the biomarkers related to DN.